XTL announces receipt of staff delisting letter from Nasdaq
Source: SeekingAlpha
2026-02-27 16:43:29 ET
More on XTL Biopharmaceuticals
- Seeking Alpha’s Quant Rating on XTL Biopharmaceuticals
- Financial information for XTL Biopharmaceuticals
Read the full article on Seeking Alpha
For further details see:
XTL announces receipt of staff delisting letter from Nasdaq
Super League Enterprise Inc.
NASDAQ: SLE
SLE Trading
-5.49% G/L:
$4.32 Last:
1,973 Volume:
$4.1029 Open:
SLE Latest News
January 28, 2026 09:00:00 am
Super League Debuts AI-Driven Playable Media Product via Exclusive Partnership with AdArcade
January 23, 2026 09:00:00 am
Super League Secures Exclusive Partnership with Solsten to Power Next Phase of Growth Through AI-Driven Audience Intelligence
January 21, 2026 08:30:00 am
Super League Enters Next Phase of Execution, Bringing the Power of Play to Modern Marketing
SLE Stock Data
$4,309,520
948,094
47.33%
5
N/A
Interactive Multi-Media
Media
US
Santa Monica
